SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by var...
Q1 2026
May 7, 2026
FY 2025
Mar 10, 2026
Q4 2025
Q3 2025
Nov 6, 2025
Q2 2025
Aug 5, 2025